Development of novel drug delivery systems for targeted cancer therapy

Thesis Overview

The project titled "Development of novel drug delivery systems for targeted cancer therapy" aims to address the pressing need for more effective and precise treatment options for cancer patients. Cancer remains a significant healthcare challenge worldwide, with conventional treatments often causing severe side effects due to their lack of specificity in targeting cancer cells. This project focuses on the development of innovative drug delivery systems that can specifically target cancer cells while minimizing damage to healthy tissues. The research will begin with a comprehensive literature review to examine current drug delivery systems used in cancer therapy, identifying their limitations and areas for improvement. This review will also explore recent advancements in nanotechnology, biomaterials, and targeted drug delivery strategies that could be applied to enhance cancer treatment outcomes. The methodology section will detail the experimental approaches and techniques that will be employed to develop and evaluate the novel drug delivery systems. This will include the synthesis of nanoparticles or other carrier systems, loading of anticancer drugs, characterization of the drug delivery systems, and in vitro and in vivo studies to assess their efficacy and safety. The discussion of findings will present the results of the experiments conducted, including the ability of the novel drug delivery systems to target cancer cells effectively, deliver therapeutic agents, and inhibit tumor growth. The discussion will also analyze the potential mechanisms of action, pharmacokinetics, and biodistribution of the drug delivery systems, providing insights into their performance and potential clinical applications. Overall, this research project aims to contribute to the field of cancer therapy by developing advanced drug delivery systems that can enhance the efficacy and safety of cancer treatment. By targeting cancer cells specifically and minimizing off-target effects, these novel systems have the potential to revolutionize cancer therapy and improve outcomes for patients.